Abstract
Endoscopic mucosal resection (EMR) is widely used in the esophagus for the management of precancerous and early superficial cancers. This is routinely performed in the management of patients with Barrett’s-related dysplasia and early esophageal adenocarcinoma (EAC) and in patients with squamous cell dysplasia and early cancer. EMR is recommended for all visible and nodular lesions, allowing for an accurate diagnosis of the grade of dysplasia. This resection method has been widely shown to be a safe and effective resection method, and various EMR techniques exist for the resection within the esophagus. The development of quality metrics for EMR will be crucial in the changing healthcare landscape, and standardized training programs will be necessary for its safe and effective use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Belghazi K, Bergman J, Pouw RE. Management of nodular neoplasia in Barrett’s esophagus: endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc Clin N Am. 2017;27(3):461–70.
Iizuka T, Kikuchi D, Hoteya S, Nakamura M, Yamashita S, Mitani T, et al. Clinical advantage of endoscopic submucosal dissection over endoscopic mucosal resection for early mesopharyngeal and hypopharyngeal cancers. Endoscopy. 2011;43(10):839–43.
Ishihara R, Iishi H, Uedo N, Takeuchi Y, Yamamoto S, Yamada T, et al. Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc. 2008;68(6):1066–72.
Balmadrid B, Hwang JH. Endoscopic resection of gastric and esophageal cancer. Gastroenterol Rep. 2015;3(4):330–8.
Barnes JA, Willingham FF. Endoscopic management of early esophageal cancer. J Clin Gastroenterol. 2015;49(8):638–46.
Deyhle P, Jenny S, Fumagalli I. Endoscopic polypectomy in the proximal colon. A diagnostic, therapeutic (and preventive?) intervention. Dtsch Med Wochenschr. 1973;98(5):219–20.
Nishizawa T, Yahagi N. Endoscopic mucosal resection and endoscopic submucosal dissection: technique and new directions. Curr Opin Gastroenterol. 2017;33(5):315–9.
Inoue H, Endo M. Endoscopic esophageal mucosal resection using a transparent tube. Surg Endosc. 1990;4(4):198–201.
Wani S, Falk GW, Post J, Yerian L, Hall M, Wang A, et al. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. Gastroenterology. 2011;141(4):1179–86, 86.e1
Kestens C, Offerhaus GJ, van Baal JW, Siersema PD. Patients with Barrett’s esophagus and persistent low-grade dysplasia have an increased risk for high-grade dysplasia and cancer. Clin Gastroenterol Hepatol. 2016;14(7):956–62.e1.
Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111(1):30–50; quiz 1
Evans JA, Early DS, Fukami N, Ben-Menachem T, Chandrasekhara V, Chathadi KV, et al. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76(6):1087–94.
Wani S, Qumseya B, Sultan S, Agrawal D, Chandrashekara V, Harnke B, et al. Endoscopic eradication therapy for patients with Barrett’s esophagus-associated dysplasia and intramucosal cancer. Gastrointest Endosc. 2018;87:907.
Peters FP, Brakenhoff KP, Curvers WL, Rosmolen WD, Fockens P, ten Kate FJ, et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus. Gastrointest Endosc. 2008;67(4):604–9.
Larghi A, Lightdale CJ, Memeo L, Bhagat G, Okpara N, Rotterdam H. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc. 2005;62(1):16–23.
Moss A, Bourke MJ, Hourigan LF, Gupta S, Williams SJ, Tran K, et al. Endoscopic resection for Barrett’s high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol. 2010;105(6):1276–83.
Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, et al. Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma – an American single-center experience. Am J Gastroenterol. 2009;104(11):2684–92.
Wani S, Abrams J, Edmundowicz SA, Gaddam S, Hovis CE, Green D, et al. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett’s esophagus patients with visible and flat neoplasia: a multicenter cohort study. Dig Dis Sci. 2013;58(6):1703–9.
Wani S, Mathur SC, Curvers WL, Singh V, Alvarez Herrero L, Hall SB, et al. Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett’s dysplasia. Clin Gastroenterol Hepatol. 2010;8(9):783–8.
Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol. 2012;107(6):850–62.. quiz 63
Panel NG. Esophageal and esophagogastric junction cancers. NCCN Clinical Practice Guidelines in Oncology [Internet]. 2017 November 19th, 2017; 4.2017. Available from: https://oncolife.com.ua/doc/nccn/Esophageal_and_Esophagogastric_Junction_Cancers.pdf.
Wani S, Qumseya B, Sultan S, Agrawal D, Chandrasekhara V, Harnke B, et al. Endoscopic eradication therapy for patients with Barrett’s esophagus-associated dysplasia and intramucosal cancer. Gastrointest Endosc. 2018;87(4):907–31.e9.
Inoue H, Takeshita K, Hori H, Muraoka Y, Yoneshima H, Endo M. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc. 1993;39(1):58–62.
Yip HC, Chiu PW. Endoscopic diagnosis and management of early squamous cell carcinoma of esophagus. J Thorac Dis. 2017;9(Suppl 8):S689–s96.
Aadam AA, Abe S. Endoscopic submucosal dissection for superficial esophageal cancer. Dis Esophagus. 2018;31(7).
Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc. 2009;70(5):860–6.
Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc. 2010;72(2):255–64, 64.e1–2
Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, Repici A, Vieth M, De Ceglie A, et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47(9):829–54.
Ning B, Abdelfatah MM, Othman MO. Endoscopic submucosal dissection and endoscopic mucosal resection for early stage esophageal cancer. Ann Cardiothorac Surg. 2017;6(2):88–98.
Yandrapu H, Desai M, Siddique S, Vennalganti P, Vennalaganti S, Parasa S, et al. Normal saline solution versus other viscous solutions for submucosal injection during endoscopic mucosal resection: a systematic review and meta-analysis. Gastrointest Endosc. 2017;85(4):693–9.
Zhang YM, Boerwinkel DF, Qin X, He S, Xue L, Weusten BL, et al. A randomized trial comparing multiband mucosectomy and cap-assisted endoscopic resection for endoscopic piecemeal resection of early squamous neoplasia of the esophagus. Endoscopy. 2016;48(4):330–8.
Schlottmann F, Patti MG, Shaheen NJ. Endoscopic treatment of high-grade dysplasia and early esophageal cancer. World J Surg. 2017;41(7):1705–11.
Kim SH, Choi HS, Chun HJ, Yoo IK, Lee JM, Kim ES, et al. A novel fixation method for variable-sized endoscopic submucosal dissection specimens: an in vitro animal experiment. PLoS One. 2016;11(1).
Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut. 2008;57(9):1200–6.
Smith I, Kahaleh M. Endoscopic versus surgical therapy for Barrett’s esophagus neoplasia. Expert Rev Gastroenterol Hepatol. 2015;9(1):31–5.
Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology. 2000;118(4):670–7.
Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146(3):652–60.e1.
Tomizawa Y, Konda VJ, Coronel E, Chapman CG, Siddiqui UD. Efficacy, durability, and safety of complete endoscopic mucosal resection of Barrett esophagus: a systematic review and meta-analysis. J Clin Gastroenterol. 2018;52:210–6.
Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL, et al. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut. 2015;64(8):1192–9.
Yamashina T, Ishihara R, Nagai K, Matsuura N, Matsui F, Ito T, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108(4):544–51.
Yoshii T, Ohkawa S, Tamai S, Kameda Y. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer. Dis Esophagus. 2013;26(5):496–502.
Pouw RE, van Vilsteren FG, Peters FP, Alvarez Herrero L, Ten Kate FJ, Visser M, et al. Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc. 2011;74(1):35–43.
Shimizu Y, Takahashi M, Yoshida T, Ono S, Mabe K, Kato M, et al. Endoscopic resection (endoscopic mucosal resection/ endoscopic submucosal dissection) for superficial esophageal squamous cell carcinoma: current status of various techniques. Dig Endosc. 2013;25(Suppl 1):13–9.
Guo HM, Zhang XQ, Chen M, Huang SL, Zou XP. Endoscopic submucosal dissection vs endoscopic mucosal resection for superficial esophageal cancer. World J Gastroenterol. 2014;20(18):5540–7.
Hammad H, Kaltenbach T, Soetikno R. Endoscopic submucosal dissection for malignant esophageal lesions. Curr Gastroenterol Rep. 2014;16(5):386.
Terheggen G, Horn EM, Vieth M, Gabbert H, Enderle M, Neugebauer A, et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia. Gut. 2017;66(5):783–93.
Isomoto H, Yamaguchi N, Minami H, Nakao K. Management of complications associated with endoscopic submucosal dissection/ endoscopic mucosal resection for esophageal cancer. Dig Endosc. 2013;25(Suppl 1):29–38.
Qumseya B, Panossian AM, Rizk C, Cangemi D, Wolfsen C, Raimondo M, et al. Predictors of esophageal stricture formation post endoscopic mucosal resection. Clin Endosc. 2014;47(2):155–61.
Lewis JJ, Rubenstein JH, Singal AG, Elmunzer BJ, Kwon RS, Piraka CR. Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett’s esophagus. Gastrointest Endosc. 2011;74(4):753–60.
Konda VJ, Gonzalez Haba Ruiz M, Koons A, Hart J, Xiao SY, Siddiqui UD, et al. Complete endoscopic mucosal resection is effective and durable treatment for Barrett’s-associated neoplasia. Clin Gastroenterol Hepatol. 2014;12(12):2002–10.e1–2.
Hashimoto S, Kobayashi M, Takeuchi M, Sato Y, Narisawa R, Aoyagi Y. The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc. 2011;74(6):1389–93.
Manner H, May A, Pech O, Gossner L, Rabenstein T, Gunter E, et al. Early Barrett’s carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol. 2008;103(10):2589–97.
Alvarez Herrero L, Pouw RE, van Vilsteren FG, ten Kate FJ, Visser M, van Berge Henegouwen MI, et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy. 2010;42(12):1030–6.
Tian J, Prasad GA, Lutzke LS, Lewis JT, Wang KK. Outcomes of T1b esophageal adenocarcinoma patients. Gastrointest Endosc. 2011;74(6):1201–6.
Ballard DD, Choksi N, Lin J, Choi EY, Elmunzer BJ, Appelman H, et al. Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection. World J Gastrointest Endosc. 2016;8(20):763–9.
Watson TJ. Esophagectomy for superficial esophageal neoplasia. Gastrointest Endosc Clin N Am. 2017;27(3):531–46.
Choi CW, Kang DH, Kim HW, Park SB, Jo WS, Song GA, et al. Comparison of endoscopic resection therapies for rectal carcinoid tumor: endoscopic submucosal dissection versus endoscopic mucosal resection using band ligation. J Clin Gastroenterol. 2013;47(5):432–6.
Hong JB, Choi CW, Kim HW, Kang DH, Park SB, Kim SJ, et al. Endoscopic resection using band ligation for esophageal SMT in less than 10 mm. World J Gastroenterol. 2015;21(10):2982–7.
Hollerbach S, Wellmann A, Meier P, Ryan J, Franco R, Koehler P. The EndoRotor((R)): endoscopic mucosal resection system for non-thermal and rapid removal of esophageal, gastric, and colonic lesions: initial experience in live animals. Endosc Int Open. 2016;4(4):E475–9.
Petersen BT. Quality assurance for endoscopists. Best Pract Res Clin Gastroenterol. 2011;25(3):349–60.
Rizk MK, Sawhney MS, Cohen J, Pike IM, Adler DG, Dominitz JA, et al. Quality indicators common to all GI endoscopic procedures. Am J Gastroenterol. 2015;110(1):48–59.
Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, et al. Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium. Gastrointest Endosc. 2017;86(1):1–17.e3.
Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, et al. Development of quality indicators for endoscopic eradication therapies in Barrett’s esophagus: the TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium. Am J Gastroenterol. 2017;112(7):1032–48.
Sharma P, Katzka DA, Gupta N, Ajani J, Buttar N, Chak A, et al. Quality indicators for the management of Barrett’s esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association symposium. Gastroenterology. 2015;149(6):1599–606.
van Vilsteren FG, Pouw RE, Herrero LA, Peters FP, Bisschops R, Houben M, et al. Learning to perform endoscopic resection of esophageal neoplasia is associated with significant complications even within a structured training program. Endoscopy. 2012;44(1):4–12.
van Vilsteren FG, Pouw RE, Alvarez Herrero L, Bisschops R, Houben M, Peters FT, et al. Learning endoscopic resection in the esophagus. Endoscopy. 2015;47(11):972–9.
Mannath J, Ragunath K. A one-to-one training program would be valuable in learning how to perform esophageal endoscopic mucosal resection. Endoscopy. 2012;44(6):632; author reply 3
Feurer ME, Draganov PV. Training for advanced endoscopic procedures. Best Pract Res Clin Gastroenterol. 2016;30(3):397–408.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Endoscopic mucosal resection of high-grade dysplasia utilizing the ligation-assisted method (MP4 154049 kb)
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Han, S., Hammad, H. (2020). Endoscopic Mucosal Resection of the Esophagus. In: Wagh, M., Wani, S. (eds) Gastrointestinal Interventional Endoscopy. Springer, Cham. https://doi.org/10.1007/978-3-030-21695-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-21695-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21694-8
Online ISBN: 978-3-030-21695-5
eBook Packages: MedicineMedicine (R0)